Novel exendin agonist formulations and methods of administration thereof
CA 2356706 C · Owner: Young, Andrew · Inventors: Young, Andrew; Kolterman, Orville; L'Italien, James J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel exendin and exendin agonist compound formulations and dosages and methods of administration thereof are provided. These compositions and methods are useful in treating diabetes and conditions that would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying or inhibiting food intake.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 14, 2000 and granted September 30, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.